Oncology Healthcare Market Scenario of India


Cancer risk is constantly on the rise with 10 lakh people diagnosed with it every year. Around 7 lakh of them die, making it one of the leading causes of death. By 2020, around 17 lakh people are expected to have cancer and deaths due to cancer will increase up to 20 percent.

With 106.6 new cancer cases in 2016 per 100,000 people, India ranked tenth among the countries with the lowest cancer incidence in an analysis by the Institute of Health Metrics and Evaluation, Washington University.

Considering the above facts Hospaccx team started working the mapping of market trends and dynamics. This is a macroficial study of a diabetic market if you want to get into more detail you can contact [email protected]


  • Oral cavity & lung cancers in men & cervix & breast cancer in females together account for 50% of cancer-related deaths in India.
  • Current Oncology market in India is found to be growing at 20% every year and will be increasing for the coming 3-5years. The cancer market in 2012 is valued at US$ 172m. There are many treatments available for cancer like chemotherapy, biologics, targeted therapy, hormonal therapy & Supportive therapy but among them in the year 2012, chemotherapy occupied the highest market value of US$ 104.97 m.

(According to Frost & Sullivan)

  • According to WHO the mortality rate is found to increase from 2007 to 2030 from 7.9 million to 11.5 million accounting for death by aged population worldwide.

The top five cancers in men and women account for 47.2% of all cancers; these cancers can be prevented, screened for and/or detected early and treated at an early stage.


  • Cancer chemotherapy came on horizon after world war-II specifically after 1940.
  • Techniques to detect cancer in earlier stages also came into picture. Active research on Molecular Biology was seen in the period between 1952 & 1971.
  • In the developed world, Paediatric oncology specialty was established in 1960s. Prior to these children with cancer were treated by adult oncologists or by paediatricians.
  • In post 1971 era Cancer chemotherapy made large strides and various drugs like Cisplatin, Adriamycin, Cyclophosphamide, Procarbazine, Mitomycin, and Bleomycin came in common use for cancer therapy.
  • Preventive aspects have again gained prime position in recent past i.e. 1993 to 1997 e.g. educating people on life style factors like nutrition and cancer, regular exercises etc. Screening the susceptible groups with respect to the age, nature of job, family history of cancer controlling environment etc.


1. Aum voice box

This medical device helps throat cancer patients, whose voice box is removed, get their voice back. Dr Vishal Rao and his team have developed this unique device.

Most throat cancer patients who undergo laryngectomy are unable to speak after the surgery due to removal of voice box. Normally, these patients go for the western prosthesis, however, the most popular european prosthesis costs around INR 25,000-30,000, which many patients cannot afford. The Aum Voice Prosthesis is priced at INR 50 (popularly known as $1 device). The device weighs 25 grams and is 2.5 cm long.

2. Cytotron to treat cancer

The CYTOTRON,a stand-alone device utilizing Rotational Field Quantum Magnetic Resonance (RFQMR) to treat cancer and improve drug targeting and delivery through nano-permeabilization. The CYTOTRON is a novel, patented therapeutic device, invented by Dr. Rajah Vijay Kumar and his team at Centre for Advanced Research and Development (CARD), the R&D wing of Scalene Cybernetics Limited, an Indian Technology company. Clinical trials for OA and Cancer have been successfully completed at CARD campus in Bangalore.

3. Nano-particle carries anti-cancer drug and releases it only in the cancerous cell

In what is being considered a path-breaking innovation, a scientist hailing from Hyderabad and his colleagues have invented a system in which a nano-particle carries the payload of anti-cancer drug and releases it only in the cancerous cell, thus protecting healthy cells around. Dr. Papineni, chief scientist and senior principal investigator in medical applications of nanotechnology at Carestream Health, Inc USA, along with his fellow researchers, filed for the patent in 2009.


  • Overall, the cancer prevalence is estimated to be 83 per 100,000 persons with a greater prevalence reported in urban population (110 per 100,000 persons).
  • The burden of cancer among elderly cohort (70+) is significantly higher at 385 per 100,000 persons.
  • However, significant prevalence of cancer among reproductive age group (15 to 49 years) is also noted (62 per 100,000 persons).
  • Elderly in urban areas have the highest cancer prevalence (727 per 100,000 persons).
  • Overall, cancer is more prevalent among females (96 per 100,000 persons) than males.
  • In addition, the cancer incidence among reproductive age group (15 to 49 years) is 3 times higher in females (96 per 100,000 persons) than males (30 per 100,000 persons).
  • The prevalence among illiterates is estimated to be 79 per 100,000 persons.


  • In India, each year nearly 6,00,000 cancer deaths occur and 5-year cancer prevalence among individuals aged 15 years and over was estimated to be 1.7 million in 2015.
  • Cancers carry high levels of mortality and disability and require expensive treatments.
  • It is found that India recorded a total productivity loss of $ 6.7 billion in 2012 due to cancer, representing 0.36% of the GDP that year.
  • The average total expenditure is estimated to be Rs 29,066 (US $ 1715.82 at 2014 Purchasing Power Parity) and Rs. 84,320 (US $ 4977.56) for the public and the private sectors, respectively.
  • The total expenditure for males (Rs. 27427) and females (Rs. 30835) is more or less similar in public sector, whereas, expenditure incurred on males is significantly higher in private facilities.
  • As expected, OOP (Out Of Pocket) expenditure is much higher for richer households. For instance, total expenditure for highest income quintile (Rs. 95422) is more than twice the average expenditure reported by the poorest quintile (Rs. 44500).
  • The overall medical expenditure is estimated to be around 80 to 90% of total expenditure on cancer inpatient treatment.
  • The non-medical expenditure also emerges as a significant component of total cancer care expenditure.


Central Government Health Scheme (CGHS): Applicable for retired Central Government employees and dependents. For providing better cancer treatment facilities to CGHS beneficiaries, one private hospital in Hyderabad and 10 Private hospitals in Delhi have been empanelled in June 2011 under CGHS exclusively for Cancer treatment as per the rates of Tata Memorial Hospital for Cancer Surgery. In addition, patient can avail cancer treatment at approved rates from any hospital, where facilities for cancer treatment are available.

Railway concession for cancer patient and one bystander: Travel for the patient is totally free. The bystander has to pay only 25% of the actual II class fare. This concession is applicable only for travel from nearest hometown station to treating cancer hospital/cancer institute and back.

 Air concession for cancer patient: Patient has to pay 50% of the basic fare of the normal economy class. This concession is applicable only for those persons who are resident of India and suffering from cancer and are travelling for the purpose of medical check-up/treatment.

Cancer Suraksha Scheme: The government of Kerala, offers the Cancer Suraksha Scheme, under which children under 18 years of age get free cancer treatment via some designated government hospitals in the state.

Aarogyasri Scheme: The government of Telangana introduced the Aarogyasri Scheme, which provides financial protection to families living below poverty line upto Rs. 2 lakhs in one year for the treatment of serious ailments requiring hospitalisation and surgery. 938 treatments are covered under the scheme. This includes cancer treatment (surgery, chemotherapy & radiation therapy).


  • Global cancer drugs market was valued at approximately USD 112.90 billion in 2015 and is expected to generate revenue of around USD 161.30 billion by end of 2021, growing at a CAGR of around 7.4% between 2016 and 2021.
  • Immunotherapy dominates the global market for cancer drugs due to its high efficacy and fewer side effects.
  • Moreover, the disposable income and reimbursement of life-threatening diseases are very high in this region which promotes the growth of cancer drugs market.
  • North America represents developed regional markets for cancer drugs and is expected to see the rapid growth in the years to come.
  • The U.S. is by far the leading cancer drugs market by country in North America.
  • Europe was the second largest regional market and is expected to show significant growth in the years to come. This growth is mainly due to an increase of patients diagnosed with cancer.
  • Asia-Pacific is expected to witness noticeable growth in the near future. In Asia, China, India, and Japan will continue to be the fastest growing markets in cancer drugs market.
  • Growth in Asia-Pacific market is expected to be driven by increasing tobacco consumption, growing population, and increasing disposable income.


  • Every year there is 20% increase in oncology market in India. Different therapies are available for cancer treatment like chemotherapy, hormonal therapy, targeted therapy & supportive care.
  • Among them chemotherapy is with highest market value of 700 Cr in 2012. In India Oncology market is forecasted to grow 3831 Cr with a compounded annual growth rate (CAGR) of 15.46% by 2017.

(Frost & Sullivan)


  • In India, restriction on use of new therapies in oncology.
  • Pricing structure of expensive cancer drugs.
  • Shortage of specialized surgical & medical oncologists in India.
  • Poor infrastructure to handle high incidence of cancer in India.


  • Increasing number of cancer cases in India.
  • Development of alternative cancer therapies; provides many options for treatment of the diseases.
  • Increase in Foreign Direct Investment (FDI) for oncology treatments.


1. Adyar Cancer Hospital, Chennai

This is one of the famous cancer centres in India. It was set up in 1954 in Chennai. It has both research and preventive facilities for cancer. It is equipped with latest technologies for cancer treatment. It is also known as the cancer institute (WIA). The Institute is a comprehensive cancer centre comprising of a hospital of 535 beds.

2. Regional Cancer Center, Trivandrum

This is a famous cancer treatment hospital in India. It is located at Trivandrum in Kerala and was founded in the year 1981 and provides treatment for various types of oncology and their surgery. It is equipped with modern facilities for treatment of cancer and has well experienced doctors and staff. This hospital focuses on research, identification, treatment and prevention of cancer.

3. MIOT Hospital, Chennai

This hospital has grown fast to become a centre of oncology. It is located in Chennai. The department of oncology was started in the year 2008.

4. Apollo Hospitals

This is one of the best cancer hospitals in India. They have branches in Hyderabad, Chennai, Delhi and Kolkata. They use advanced equipments like Cyber Knife, Positron Emission Tomography and Novalis radio surgery for cancer treatment.

5. Tata Memorial Hospital, Mumbai

It is one of the famous cancer care hospitals in Mumbai. It was set up in the year 1952.

6. P.D. Hinduja National Hospital, Mumbai

It is located in Mumbai & was started in the 1950s. It is one of the best cancer treatment hospitals in India & they have expertise in providing treatment for breast cancer and bladder cancer.

7. Kidwai Institute Of Oncology, Bangalore

This hospital is located in Bangalore & was founded in the year 1973. This hospital with 50 beds is considered to be one of the top cancer care hospitals in India.

8. Max Institute Of Oncology, Delhi

This is one of the leading cancer treatment hospitals in Delhi. It has branches in Punjab and Gurgaon. It provides treatments for lung cancer, head cancer, neck cancer, blood caner, breast cancer, cervical cancer and gastrointestinal cancer.

9. Harshamitra Super Speciality Cancer Centre, Trichy

This is a fast growing cancer hospital in Trichy district of Tamil Nadu. This hospital was set up in the year 2010. They provide treatments like radiation, medicines and surgery. This is the first hospital in India to introduce the scheme of tumour board as a process for the treatment of cancer.

10. Amala Cancer Hospital, Thrissur

This 100 bedded hospital is located in Thrissur district of Kerala and established in 1982. It is one of the best hospital in India for treatment & prevention of cancer. They also use ayurvedic medicines for treatment of cancer. They offer services for diagnosis, prevention, research and treatment of cancer.

11. Christian Medical College (CMC), Vellore

CMC Vellor’es Medical Oncology services are provided by a multidisciplinary team. It has Medical Oncologists, Physicians, Nurses, Clinical Pharmacists, and Pastoral Care professionals. This team provides care through all stages of cancer care including supportive care whenever needed. The department specializes in the treatment of cancers with chemotherapy and other biological therapies.


  • The growing number cancer patient in India, mainly due to poor strategy where physicians concentrate on treatment rather than prevention and screening.
  • A large group of patients remain untapped and do not receive the medical treatment, due to insufficient number of oncologist and drugs.
  • 5 years ago the number of cases diagnosed was 250 but today it is doubled that is 500 new cases which raise huge concerns for treatment.
  • Hence, India needs oncologists and healthcare sectors to give cancer patients the required treatment.

Are you planning to build or restructure or venture in Oncology Hospital in India? Looking for information about the major healthcare players in Government, Private diagnostic centres that are available in India? Are you looking to find out which part of the city’s is best to venture in or what all facilities are available and what all should be planned for new setup? In this article Hospaccx Healthcare Consultancy has mapped all on major players in terms of Oncology facilities and healthcare scenario in India.

Below is the superficial and macro level survey if you need a refined market and financial feasibility or any other study related to healthcare is required you can contact Hospaccx Healthcare business consulting Pvt. ltd on [email protected] or [email protected] Or you can visit our website on www.hhbc.in

Please follow and like us: